Effect of Cinnamon on diabetes
Phase 2
- Conditions
- diabetes.typeII,Non-insulin-dependent diabetes mellitus
- Registration Number
- IRCT2017031133015N1
- Lead Sponsor
- Shiraz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 120
Inclusion Criteria
informed consent to participate in the study; patients with type 2 diabetes; Patients who only use oral medications to control their blood sugar ;Lack of disease or complications of diabetes ; body mass index between 18.5 and 40 ; Patients with a fasting blood glucose between 126 to 250 milligrams per deciliter .
Exclusion criteria: People who change during the study their treatment to insulin ; Lack of regular use of oral capsules (including cinnamon or placebo) ;sensitivity to other diseases during the study drug ; Cancel participate on the study; patients with a BMI of less than 18.5 (thin) and patients with a body mass index over 40 (morbid obese)
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Fasting blood glucose. Timepoint: at onset and after 3 months. Method of measurement: blood sample.;Glycosylated Hemogolobine. Timepoint: at onset and after 3 months. Method of measurement: blood sample.;2hours post parandial glougose. Timepoint: at onset and after 3 months. Method of measurement: blood sample.
- Secondary Outcome Measures
Name Time Method Mezaj. Timepoint: onset. Method of measurement: questionary.;Body activity. Timepoint: onset. Method of measurement: questionary.;Calery intake. Timepoint: onset. Method of measurement: food frequency questionary.;Triglyceride. Timepoint: at onset and after 3 months. Method of measurement: blood sample.;Colstrol. Timepoint: at onset and after 3 months. Method of measurement: blood sample.;Weight. Timepoint: at onset and after 3 months. Method of measurement: digital scale (OMRON BF511).;Body mass indwx. Timepoint: at onset and after 3 months. Method of measurement: digital scale (OMRON BF511).;Fat mass percentage. Timepoint: at onset and after 3 months. Method of measurement: digital scale (OMRON BF511).;Muscle mass index. Timepoint: at onset and after 3 months. Method of measurement: digital scale (OMRON BF511).;Hdl. Timepoint: at onset and after 3 months. Method of measurement: blood sample.;Ldl. Timepoint: at onset and after 3 months. Method of measurement: blood sample.